CNS Drugs

, Volume 24, Issue 8, pp 639–653 | Cite as

The Relationship between Benzodiazepine Use and Traffic Accidents

A Systematic Literature Review
  • Beitske E. Smink
  • Antoine C. G. Egberts
  • Klaas J. Lusthof
  • Donald R. A. Uges
  • Johan J. de Gier
Review Article

Abstract

In many countries, benzodiazepines are the most commonly used and misused psychoactive medicinal drugs. Results of epidemiological studies investigating the association between benzodiazepine use and traffic accidents seem to be inconclusive or inconsistent at first sight. However, the outcome of epidemiological studies may be influenced by several methodological factors like study design, study population, exposure measurement, outcome definitions and possible confounders.

Our objective was to conduct a systematic literature review of epidemiological studies that investigated the association between benzodiazepine use and traffic accidents, including related outcomes like culpability and injury or accident severity. We searched EMBASE, PubMed and Forensic Science Abstracts 3/0 (FORS®) for references included in these databases at 1 June 2009 using the term ‘benzodiazepines’ in combination with ‘driving performance’ or ‘accident risk’ or ‘traffic accident’. For inclusion in this review, the study design had to be comparative, include road users involved in accidents and provide specific data about benzodiazepines. Sixty-six studies were included in the review. The study populations varied from the general (driving) population, accident-involved road users with or without injury and persons admitted to a hospital to fatally injured accident-involved drivers. Exposure assessment was performed by using toxicological results, prescription data or questionnaires.The divergent study populations and comparison groups and the variety of methods used to express the outcome of interest hampered comparison between results.

Evidence is growing that exposure to benzodiazepines is related to increased accident risk. The literature indicates that the greatest accident risk is associated with the use of long half-life benzodiazepines, increasing dosage and the first few weeks of use of benzodiazepines. Clear evidence of increased culpability associated with benzodiazepine use is scarce. More research has to be done to elucidate the relationship between benzodiazepine use and injury severity.

Keywords

Traffic Accident Zolpidem Zopiclone Standardize Incidence Ratio Blood Alcohol Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

Supplementary material

40263_2012_24080639_MOESM1_ESM.pdf (227 kb)
Supplementary material, approximately 232 KB.

References

  1. 1.
    Walsh JM, De Gier JJ, Christophersen AS, et al. Drugs and driving. Traffic Inj Prev 2004; 5: 241–53PubMedCrossRefGoogle Scholar
  2. 2.
    Murray N. Metaminodiazepoxyde. JAMA 1960; 173: 1760–1CrossRefGoogle Scholar
  3. 3.
    Friedel B, Staak M. Benzodiazepines and driving. Rev Contemp Pharmacother 1992: V3-474Google Scholar
  4. 4.
    Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004; 18: 297–328PubMedCrossRefGoogle Scholar
  5. 5.
    Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev 2004; 8: 309–25PubMedCrossRefGoogle Scholar
  6. 6.
    De Gier JJ. Problems raised by the use/abuse of psychoactive drugs by drivers: report on the situation in 24 European countries. Proceedings of Road Traffic and Psychoactive Substances Seminar organised by the Pompidou Group; 2003 Jun 18–20; StrasbourgGoogle Scholar
  7. 7.
    Foundation for Pharmaceutical Statistics. Facts and figures 2006 [online]. Available from URL: http://www.sfk.nl/algemeen/english.html [Accessed 2010 Apr 29]
  8. 8.
    Jones AW. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances. Traffic Inj Prev 2005; 6: 317–22PubMedCrossRefGoogle Scholar
  9. 9.
    Mykkanen S, Lillsunde P. The handling and statistics of suspected drugs and driving cases in Finland. Proceedings of the conference of the International Association of Forensic Toxicologists; 2006 Aug 27–Sept 1; LjubljanaGoogle Scholar
  10. 10.
    Drummer OH, Gerostamoulos J, Batziris H, et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int 2003; 34: 154–62CrossRefGoogle Scholar
  11. 11.
    Kurzthaler I, Wambacher M, Golser K, et al. Alcohol and/or benzodiazepine use in injured road users. Hum Psychopharmacol 2003; 18: 361–7PubMedCrossRefGoogle Scholar
  12. 12.
    Longo MC, Hunter CE, Lokan RJ, et al. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part I. The prevalence of drug use in drivers, and characteristics of the drug-positive group. Accid Anal Prev 2000; 32: 613–22Google Scholar
  13. 13.
    Meulemans A, Hooft P, Van Camp L, et al. Belgian Toxicology and Trauma Study (BTTS): a study on alcohol, medication and illicit drugs in drivers/victims of road traffic accidents. Report 1998; NK-101Google Scholar
  14. 14.
    Mura P, Kintz P, Ludes B, et al. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int 2003; 133: 79–85PubMedCrossRefGoogle Scholar
  15. 15.
    Smink BE, Ruiter B, Lusthof KJ, et al. Driving under the influence of alcohol and/or drugs in the Netherlands 1995–1998 in view of the German and Belgian legislation. Forensic Sci Int 2001; 120: 195–203PubMedCrossRefGoogle Scholar
  16. 16.
    Rapoport MJ, Banina MC. Impact of psychotropic medications on simulated driving: a critical review. CNS Drugs 2007; 21: 503–19PubMedCrossRefGoogle Scholar
  17. 17.
    Strom BL. Data validity issues in using claims data. Pharmacoepidemiol Drug Saf 2001; 10: 389–92PubMedCrossRefGoogle Scholar
  18. 18.
    Strom BL. Methodologic challenges to studying patient safety and comparative effectiveness. Med Care 2007; 45(10 Suppl. 2): S13–5PubMedCrossRefGoogle Scholar
  19. 19.
    Embase Biomedical Answers [online]. Available from URL: http://www.embase.com [Accessed 2009 Jun 1]
  20. 20.
    National Centre for Biotechnology Information [online]. Available from URL: http://www.ncbi.nlm.nih.gov [Accessed 2009 Jun 1]
  21. 21.
    Forensic Science Service [online]. Available from URL: http://www.forensic.gov.uk [Accessed 2009 Jun 1]
  22. 22.
    Bo O, Haffner JWF, Langart O, et al. Ethanol and diazepam as causative in road traffic accidents. Proceedings of the 6th International Conference on Alcohol, Drugs and Traffic Safety; 1975 Sep 8–13; Toronto (ON), 439-48Google Scholar
  23. 23.
    Bouchard J, Brault M. Link between driving records and the presence of drugs and/or alcohol in fatally injured drivers. Proceeding of the 17th International Conference on Alcohol, Drugs and Traffic Safety; 2004 Aug 8–13; GlasgowGoogle Scholar
  24. 24.
    Christensen LQ, Nielsen LM, Nielsen SL. Traffic accidents and drivers suspected for drug influence. Forensic Sci Int 1990; 45: 273–80PubMedCrossRefGoogle Scholar
  25. 25.
    Christophersen AS, Beylich KM, Bjorneboe A, et al. Prevalence of alcohol and drugs in blood samples from Norwegian drivers in road traffic accidents. Proceedings of the 13th International Conference on Alcohol, Drugs and Traffic Safety; 1995 Aug 13–18; Adelaide (SA), 768-72Google Scholar
  26. 26.
    Cimbura G, Lucas DM, Bennett RC, et al. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. J Forensic Sci 1982; 27: 855–67PubMedGoogle Scholar
  27. 27.
    Dussault S, Brault M, Bouchard J, et al. The contribution of alcohol and other drugs among fatally injured drivers in Québec: some preliminary results. Proceeding of the 16th International Conference on Alcohol Drugs and Traffic Safety; 2002; Aug 4–9; Québec (QC), 423-30Google Scholar
  28. 28.
    Engeland A, Skurtveit S, Morland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol 2007; 17: 597–602PubMedCrossRefGoogle Scholar
  29. 29.
    French DD, Chirikos TN, Spehar A, et al. Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a veterans population. Drug Saf 2005; 28: 1141–50PubMedCrossRefGoogle Scholar
  30. 30.
    Gibson JE, Hubbard RB, Smith CJP, et al. Use of self-controlled analytical techniques to assess the association between use of prescription medications and the risk of motor vehicle crashes. Am J Epidemiol 2009; 169: 761–8PubMedCrossRefGoogle Scholar
  31. 31.
    Gustavsen I, Bramness JG, Skurtveit S, et al. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9: 818–22PubMedCrossRefGoogle Scholar
  32. 32.
    Hebert C, Delaney JA, Hemmelgarn B, et al. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs. Pharmacoepidemiol Drug Saf 2007; 16: 845–9PubMedCrossRefGoogle Scholar
  33. 33.
    Hemmelgarn B, Suissa S, Huang A, et al. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278: 27–31PubMedCrossRefGoogle Scholar
  34. 34.
    Honkanen R, Ertama L, Linnoila M, et al. Role of drugs in traffic accidents. Br Med J 1980; 281: 1309–12PubMedCrossRefGoogle Scholar
  35. 35.
    Jacobson B, Ysander L, Ojerskog B. Alcohol and drugs in road traffic accident victims. J Traffic Med 1983; 11: 28–33Google Scholar
  36. 36.
    Jick H, Hunter JR, Dinan BJ, et al. Sedating drugs and automobile accidents leading to hospitalization. Am J Public Health 1981; 71: 1399–400PubMedCrossRefGoogle Scholar
  37. 37.
    Leveille SG, Buchner DM, Koepsell TD, et al. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 1994; 5: 591–8PubMedCrossRefGoogle Scholar
  38. 38.
    MacDonald T. The impact of psychotropic medication on daily activities: psychotropic drugs and road traffic accidents: the MEMO Study. Prim Care Psychiatry 1999; 5: S13–6Google Scholar
  39. 39.
    MacPherson RD, Perl J, Starmer GA. Self-reported drug usage and crash-incidence in breathalyzed drivers. Accid Anal Prev 1984; 16: 139–48CrossRefGoogle Scholar
  40. 40.
    McGwin G, Sims RV, Pulley L, et al. Relations among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based case-control study. Am J Epidemiol 2000; 152: 424–31PubMedCrossRefGoogle Scholar
  41. 41.
    Movig KL, Mathijssen MP, Nagel PH, et al. Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 2004; 36: 631–6PubMedCrossRefGoogle Scholar
  42. 42.
    Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5: 239–44PubMedCrossRefGoogle Scholar
  43. 43.
    Neutel CI, Downey W, Senft D. Medical events after a prescription for a benzodiazepine. Pharmacoepidemiol Drug Saf 1995; 4: 63–73CrossRefGoogle Scholar
  44. 44.
    Neutel I. Benzodiazepine-related traffic accidents in young and elderly drivers. Hum Psychopharmacol 1998; 13: S115-23Google Scholar
  45. 45.
    Oster G, Russell MW, Huse DM, et al. Accident- and injury-related health-care utilization among benzodiazepine users and nonusers. J Clin Psychiatry 1987; 48: 17–21PubMedGoogle Scholar
  46. 46.
    Oster G, Huse DM, Adams SF, et al. Benzodiazepine tranquilizers and the risk of accidental injury. Am J Public Health 1990; 80: 1467–70PubMedCrossRefGoogle Scholar
  47. 47.
    Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992; 136: 873–83PubMedCrossRefGoogle Scholar
  48. 48.
    Rapoport MJ, Herrmann N, Molnar F, et al. Psychotropic medications and motor vehicle collisions in patients with dementia. J Am Geriatr Soc 2008; 56: 1968–70PubMedCrossRefGoogle Scholar
  49. 49.
    Skegg DC, Richards SM, Doll R. Minor tranquillisers and road accidents. Br Med J 1979; 1: 917–9PubMedCrossRefGoogle Scholar
  50. 50.
    Tamblyn R, Abrahamowicz M, du Berger R, et al. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005; 53: 233–41PubMedCrossRefGoogle Scholar
  51. 51.
    Wadsworth EJ, Moss SC, Simpson SA, et al. Preliminary investigation of the association between psychotropic medication use and accidents, minor injuries and cognitive failures. Hum Psychopharmacol 2003; 18: 535–40PubMedCrossRefGoogle Scholar
  52. 52.
    Wadsworth EJK, Moss SC, Simpson SA, et al. Psychotropic medication use and accidents, injuries and cognitive failures. Hum Psychopharmacol 2005; 20: 391–400PubMedCrossRefGoogle Scholar
  53. 53.
    ‘Benzodiazepine/Driving’ Collaborative Group. Are benzodiazepines a risk factor for road accidents? Drug Alcohol Depend 1993; 33: 19–22CrossRefGoogle Scholar
  54. 54.
    Currie D, Hashemi K, Fothergill J, et al. The use of anti-depressants and benzodiazepines in the perpetrators and victims of accidents. Occup Med 1995; 45: 323–5CrossRefGoogle Scholar
  55. 55.
    Drummer OH, Gerostamoulos J, Batziris H, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev 2004; 36: 239–48PubMedCrossRefGoogle Scholar
  56. 56.
    Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet 1998; 352: 1331–6PubMedCrossRefGoogle Scholar
  57. 57.
    Dubois S, Bédard M, Weaver B. The impact of benzo-diazepines on safe driving. Traffic Inj Prev 2008; 9: 404–13PubMedCrossRefGoogle Scholar
  58. 58.
    Garriott JC, DiMaio VJ, Zumwalt RE, et al. Incidence of drugs and alcohol in fatally injured motor vehicle drivers. J Forensic Sci 1977; 22: 383–9PubMedGoogle Scholar
  59. 59.
    Longo MC, Hunter CE, Lokan RJ, et al. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part II. The relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev 2000; 32: 623–32Google Scholar
  60. 60.
    Terhune KW. The role of alcohol, marijuana and other drugs in the accidents of injured drivers: report no. DOT HS 501 179. Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration, 1982Google Scholar
  61. 61.
    Terhune KW. The incidence and role of drugs in fatally injured drivers: report no. DOT HS 808 065. Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration, 1992Google Scholar
  62. 62.
    Williams AF, Peat MA, Crouch DJ, et al. Drugs in fatally injured young male drivers. Public Health Rep 1985; 100: 19–25PubMedGoogle Scholar
  63. 63.
    Adams JE, Davis GG, Alexander CB, et al. Pelvic trauma in rapidly fatal motor vehicle accidents. J Orthop Trauma 2003; 17: 406–10PubMedCrossRefGoogle Scholar
  64. 64.
    Ahlm K, Björnstig U, Oström M. Alcohol and drugs in fatally and non-fatally injured motor vehicle drivers in northern Sweden. Accid Anal Prev 2009; 41: 129–36PubMedCrossRefGoogle Scholar
  65. 65.
    Barnas C, Miller CH, Sperner G, et al. The effects of alcohol and benzodiazepines on the severity of ski accidents. Acta Psychiatr Scand 1992; 86: 296–300PubMedCrossRefGoogle Scholar
  66. 66.
    Kirby JM, Maull KI, Fain W. Comparability of alcohol and drug use in injured drivers. South Med J 1992; 85: 800–2PubMedCrossRefGoogle Scholar
  67. 67.
    Kurzthaler I, Wambacher M, Golser K, et al. Alcohol and/or benzodiazepine use: different accidents —different impacts? Hum Psychopharmacol 2005; 20: 583–9PubMedCrossRefGoogle Scholar
  68. 68.
    Levy RS, Hebert CK, Munn BG, et al. Drug and alcohol use in orthopedic trauma patients: a prospective study. J Orthop Trauma 1996; 10: 21–7PubMedCrossRefGoogle Scholar
  69. 69.
    Rivara FP, Mueller BA, Fligner CL, et al. Drug use in trauma victims. J Trauma 1989; 29: 462–70PubMedCrossRefGoogle Scholar
  70. 70.
    Sjogren H, Bjornstig U, Eriksson A, et al. Drug and alcohol use among injured motor vehicle drivers in Sweden: prevalence, driver, crash, and injury characteristics. Alcohol Clin Exp Res 1997; 21: 968–73PubMedCrossRefGoogle Scholar
  71. 71.
    Smink BE, Movig KLL, Lusthof KJ, et al. The relation between the use of psychoactive substances and the severity of the injury in a group of crash-involved drivers admitted to a regional trauma center. Traffic Inj Prev 2008; 9: 105–8PubMedCrossRefGoogle Scholar
  72. 72.
    Stoduto G, Vingilis E, Kapur BM, et al. Alcohol and drug use among motor vehicle collision victims admitted to a regional trauma unit: demographic, injury, and crash characteristics. Accid Anal Prev 1993; 25: 411–20PubMedCrossRefGoogle Scholar
  73. 73.
    Bramness JG, Skurtveit S, Morland J. Clinical impairment of benzodiazepines: relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend 2002; 68: 131–41PubMedCrossRefGoogle Scholar
  74. 74.
    Bramness JG, Skurtveit S, Morland J. Testing for benzodiazepine inebriation: relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers. Eur J Clin Pharmacol 2003; 59: 593–601PubMedCrossRefGoogle Scholar
  75. 75.
    Kuitunen T, Aranko K, Nuotto E, et al. The relationship between blood benzodiazepine concentrations and the clinical test for drunkenness in drivers suspected of driving under the influence of drugs. Alcohol Drug Driving 1994; V10-146Google Scholar
  76. 76.
    Kuitunen T, Meririnne E, Seppala T. Correlation between blood diazepam concentrations and performance on the clinical test for drunkenness in acute and chronic diazepam users. J Traffic Med 1994; 22: 105–11Google Scholar
  77. 77.
    Missen AW, Cleary W, Eng L, et al. Diazepam, alcohol and drivers. N Z Med J 1978; 87: 275–7PubMedGoogle Scholar
  78. 78.
    Smink BE, Lusthof KJ, de Gier JJ, et al. The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers. J Forensic Leg Med 2008; 15: 483–8PubMedCrossRefGoogle Scholar
  79. 79.
    Vinkers DJ, Gussekloo J, Van Der Mast RC, et al. Benzodiazepine use and risk of mortality in individuals aged 85 years or older. JAMA 2003; 290: 2942–3PubMedCrossRefGoogle Scholar
  80. 80.
    IMMORTALR4. 2. The prevalence of drug driving and relative risk estimations: a study conducted in The Netherlands, Norway and the United Kingdom, 2005 Jun 22 [online]. Available from URL: http://www.immortal.or.at/deliverables.php#top [Accessed 2010 Apr 15]
  81. 81.
    Binnie GAC. Psychotropic drugs and accidents in a general practice. Br Med J 1983; 287: 1349CrossRefGoogle Scholar
  82. 82.
    Smink BE, Ruiter B, Lusthof KJ, et al. Drug use and the severity of a traffic accident. Accid Anal Prev 2005; 37: 427–33PubMedCrossRefGoogle Scholar
  83. 83.
    Longo MC, Lokan RJ, White JM. The relationship between blood benzodiazepine concentration and vehicle crash culpability. J Traffic Med 2001; 29: 36–43Google Scholar
  84. 84.
    Verster JC, Volkerts ER, Olivier B, et al. Zolpidem and traffic safety: the importance of treatment compliance. Curr Drug Saf 2007; 2: 220–6PubMedCrossRefGoogle Scholar
  85. 85.
    Gustavsen I, Al-Sammurraie M, Morland J, et al. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev 2009; 41: 462–6PubMedCrossRefGoogle Scholar
  86. 86.
    Robertson MD, Drummer OH. Responsibility analysis: a methodology to study the effects of drugs in driving. Accid Anal Prev 1994; 26: 243–7PubMedCrossRefGoogle Scholar
  87. 87.
    Van Laar MW, Volkerts ER. Driving and benzodiazepine use: evidence that they do not mix. CNS Drugs 1998; 10: 383–96CrossRefGoogle Scholar
  88. 88.
    O’Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 2005; 66 Suppl. 2: 28–33Google Scholar
  89. 89.
    Riss J, Cloyd J, Gates J, et al. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 2008; 118: 69–86PubMedCrossRefGoogle Scholar
  90. 90.
    Rapoport MJ, Lanctot KL, Streiner DL, et al. Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry 2009; 70: 663–73PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  • Beitske E. Smink
    • 1
  • Antoine C. G. Egberts
    • 2
    • 3
  • Klaas J. Lusthof
    • 1
  • Donald R. A. Uges
    • 4
    • 5
  • Johan J. de Gier
    • 6
  1. 1.Department of ToxicologyNetherlands Forensic InstituteThe Haguethe Netherlands
  2. 2.Department of Pharmacoepidemiology and PharmacotherapyUtrecht Institute for Pharmaceutical SciencesUtrechtthe Netherlands
  3. 3.Department of Clinical PharmacyUniversity Medical CentreUtrechtthe Netherlands
  4. 4.Department of Pharmacy, Toxicology and Forensic MedicineUniversity Medical Center GroningenGroningenthe Netherlands
  5. 5.Department of Analytical Biochemistry, Groningen Research Institute for PharmacyUniversity of GroningenGroningenthe Netherlands
  6. 6.Department of Pharmacotherapy and Pharmaceutical Care, Groningen Research Institute for PharmacyUniversity of GroningenGroningen

Personalised recommendations